Skip to main content
. 2018 Apr 3;9(25):17675–17688. doi: 10.18632/oncotarget.24832

Table 5. Summary statistics on exposure metrics stratified by dose level.

Geometric Mean (CV%)
Dose level (mg/kg) 0.015 0.3 1 3 6 10
N 12 3 4 12 3 3
Cmax (ng/mL) 297
(50.9)
5,722
(35.7)
24,650
(20.4)
76,126
(25.7)
152,872 (7.51) 197,890 (7.02)
Cmax/dose (ng/mL)/µg 0.251
(52.5)
0.334
(33.1)
0.384
(21.6)
0.345
(25.0)
0.42(5.78) 0.290
(8.28)
Cmin (28 days) (ng/mL) 8.56
(370)
972
(65.6)
5615
(9.79)
13,935
(31.9)
29,810
(19.4)
39,455
(36.3)
AUC0–28 (ng·day/mL) 1519
(70.2)
49,240 (47.4) 263,355 (11.8) 719,907
(20.8)
1,347,718 (16.7) 2,006,586 (12.2)
AUC0–28 /dose (ng·day/mL)/µg 1.28
(78.4)
2.88
(28.8)
4.10
(11.6)
3.26
(20.7)
3.74
(11.0)
2.94
18.0)

N: Number of patients; CV%: coefficient of variation of the geometric mean; Cmax: maximum concentration; Cmin (28 days): trough concentration at day 28; AUC0–28: AUC single dose between 0 and day 28; Dose: actual dose in µg.